PDS Planning Inc raised its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 2.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,040 shares of the semiconductor company’s stock after buying an additional 24 shares during the period. PDS Planning Inc’s holdings in Synopsys were worth $527,000 as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in the company. ORG Partners LLC boosted its stake in Synopsys by 600.0% in the second quarter. ORG Partners LLC now owns 42 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 36 shares in the last quarter. Chris Bulman Inc bought a new position in shares of Synopsys in the second quarter worth about $30,000. Pacifica Partners Inc. bought a new stake in shares of Synopsys during the third quarter valued at approximately $25,000. Tsfg LLC increased its holdings in shares of Synopsys by 75.0% in the third quarter. Tsfg LLC now owns 56 shares of the semiconductor company’s stock valued at $28,000 after purchasing an additional 24 shares in the last quarter. Finally, Fortitude Family Office LLC raised its position in Synopsys by 66.7% in the 2nd quarter. Fortitude Family Office LLC now owns 60 shares of the semiconductor company’s stock worth $36,000 after purchasing an additional 24 shares during the last quarter. 85.47% of the stock is owned by institutional investors.
Synopsys Trading Up 1.2 %
SNPS opened at $524.52 on Tuesday. The firm’s fifty day simple moving average is $504.93 and its 200 day simple moving average is $544.14. The stock has a market capitalization of $80.57 billion, a P/E ratio of 54.41, a P/E/G ratio of 3.16 and a beta of 1.08. Synopsys, Inc. has a 12 month low of $457.52 and a 12 month high of $629.38.
Insider Activity
In related news, CEO Sassine Ghazi sold 10,293 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $553.89, for a total transaction of $5,701,189.77. Following the completion of the transaction, the chief executive officer now directly owns 62,568 shares of the company’s stock, valued at approximately $34,655,789.52. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.66% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on SNPS shares. Needham & Company LLC reaffirmed a “buy” rating and set a $640.00 price target on shares of Synopsys in a research note on Tuesday, October 22nd. Piper Sandler cut their price objective on shares of Synopsys from $687.00 to $670.00 and set an “overweight” rating on the stock in a report on Thursday, October 24th. Robert W. Baird lifted their target price on shares of Synopsys from $661.00 to $663.00 and gave the stock an “outperform” rating in a report on Thursday, August 22nd. Berenberg Bank assumed coverage on Synopsys in a research report on Tuesday, October 15th. They issued a “buy” rating and a $660.00 price target on the stock. Finally, JPMorgan Chase & Co. upped their price objective on Synopsys from $655.00 to $685.00 and gave the company an “overweight” rating in a report on Thursday, August 22nd. Twelve analysts have rated the stock with a buy rating, Based on data from MarketBeat, Synopsys presently has a consensus rating of “Buy” and a consensus price target of $643.00.
View Our Latest Stock Report on Synopsys
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Intel: Is Now the Time to Be Brave?Â
- Market Cap Calculator: How to Calculate Market Cap
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Investing In Preferred Stock vs. Common Stock
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.